Triple-Negative Breast Cancer: Modern Treatment Strategies and Ongoing Clinical Trials
Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options. Learn about modern therapies like immunotherapy, PARP inhibitors, antibody-drug conjugates, and emerging personalized vaccines that are changing survival outcomes.